Culture Development Industry News
-
DSM Announces License Agreement With Amgen For Use Of DSM's XD® Cell Culture Patents
1/15/2013
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed a non-exclusive license agreement with Amgen Inc. for access to DSM's proprietary XD® high cell density process patents.
-
Cell Culture - Rising Demand For Biologics And Growing Visibility Of Approval Pathway For Biosimilars Will Create Growth Opportunities
11/19/2012
GBI Research, the leading business intelligence provider, has released its latest research "Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities", which provides in-depth analysis on the processes, drivers and barriers of the cell culture market.
-
Sigma® Life Science Launches Novel, Affordable Pluripotent Stem Cell Culture Medium
10/15/2012
Sigma-Aldrich® Corp. announced that Sigma Life Science, its innovative biological products and services research business, has launched Stemline® Pluripotent Culture Medium, a novel human pluripotent stem cell culture medium that provides a consistent environment for the long-term maintenance and growth of healthy pluripotent stem cells.